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which was incident upon the target. The resulting bremsstrahlung x-
ray beam was then propagated through the simulated machine and 
into a phantom. A scoring plane at the surface of the phantom was 
used to compute the backscatter factor (Bw) and the mass-energy 
absorption coefficient ratio [(μen/ρ)w/air]air. The chamber factor (kch) 
was also measured experimentally by comparing the chamber reading 
with the dose obtained using the backscatter-factor method. 
Results: The HVL was calculated to be 0.9 mm Al similar to the 
experimental value of 0.77 mm Al. Simulated PDD curves agreed well 
with previous measurements. The mass-energy absorption coefficient 
for water to air at the surface of a water phantom was found to be 
1.023 + 0.001 consistent with the value in the current UK code of 
practice for the same quality index. The backscatter factor was 
estimated to be 1.05 + 0.005 for an 11 mm field radius as shown by 
Figure 1. This reduces the value of a dose measurement by 
approximately 1% relative to the current UK code of practice value 
based on published studies. The value of the chamber correction 
factor kch obtained through measurement using low and very low 
energy codes was 1.04 + 0.01, lower than the 1.06 currently in the 
code of practice but within the uncertainties in the original studies. 
 
 
Conclusions: The values for the calibration coefficients generated in 
this study are close to those in the UK code of practice. A difference 
of 2% was found for the chamber factor but this coefficient is known 
to be subject to large uncertainties of which the code of practice 
gives a representative value. Work is continuing to model the 
PTW23342 ionisation chamber and produce a chamber factor via 
Monte Carlo simulation. Initial results are higher than experimental 
values. 
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Purpose/Objective: For the TrueBeamTM linac, the vendors (Varian 
Medical Systems) only include detailed information on the components 
from the secondary collimators and downstreams in their Monte Carlo 
data package. In order to describe the upper part of the TrueBeam 
linac the vendor supply phase space files (PSF). This leads to 
consequences for the user; it is no longer possible to commission the 
Monte Carlo (MC) model against a specific linac. Moreover, the 
number of unique particles is limited by the size of the PSF, thereby 
limiting the achievable accuracy in dose calculations. The term 'latent 
variance' was coined by Sempau et al. (2001) and refers to the limit on 
the achievable total variance as a consequence of the number of 
particles in the PSF being finite. The purpose of this study was to 
determine the latent standard deviation of the vendor supplied 
TrueBeam PSFs for a clinically relevant situation  
Materials and Methods: The total variance of a patient and/or 
phantom simulation is a combination of the latent variance of the PSF, 
A, and the statistical variance of the dose scoring simulation, B. 
  
where N is the number of simulated histories.  
By employing a K-fold recycling of the PSF particles equation 1 can be 
rewritten as 
 
 The total variance can be represented as a function of K-1 and fitted 
to a straight line. The latent variance of the PSF is given by the 
crossing of this line with the axis K-1=0.  
The most recent TrueBeam PSFs were downloaded from 
myVarian.com. A 10×10 cm2 field was simulated in BEAMnrc using 
combined and trigometrically 'flattened' PSFs for each energy and 
fluence mode as input. No variance reductions were employed and 
PSFs were scored at 90 cm SSD. 
DOSXYZnrc was employed to score dose in a 40×40×40 cm3 
homogeneous water phantom using the 10×10 cm2 field PSFs as input 
directly on the phantom surface. The voxel size was 0.25×0.25×0.25 
cm3 and the variance in the 27 voxels located around the beam 
isocenter was scored.  
Results: The total variance, q, as a function of the inverse recycling 
rate, K-1, is shown in figure 1. The latent SD for each energy and mode 
is shown in table 1. 
 
  
Table 1. Absolute and relative latent standard deviation for each 
energy and mode studied. The relative latent standard deviation is 
given with respect to the dose of the isocenter voxel. 
Nominal 
Energy 
(MeV) 
Mode Latent SD 
(eV cm2 g-1 per 
history) 
Relative Latent 
SD  
(%) 
6 Flattened 6.13±0.46 1.02±0.08 
6 FFF 13.07±0.98 0.85±0.14 
10 Flattened 12.04±1.94 0.74±0.06 
10 FFF 26.45±1.58 0.41±0.02 
 
Conclusions: The latent SDs of the vendor supplied TrueBeam PSFs 
were determined for a clinically relevant situation. The latent SD is 
most likely sufficiently low for many applications (e.g. MC based 
patient specific QA), but inadequate if the goal is to perform 
simulations requiring a high level of accuracy (e.g.computation of 
correction factors). MC is often considered the golden standard in 
comparison of dose calculation algorithms. Regardless of the level of 
the latent SD, such studies would be biased as other algorithms 
typically are based on dose measurements for a specific linac, 
whereas the PSFs are generic.  
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Purpose/Objective: In proton therapy, complex density 
heterogeneities within the beam path pose a challenge to analytical 
dose calculation algorithms so that the reliability of the predicted 
dose distributions might be questioned. For these cases in which 
substantial dose errors are expected, resorting to more accurate 
Monte Carlo (MC) simulations might be essential to ensure a successful 
treatment outcome and therefore the benefit is worth a presumably 
long computation time. The aim of this study was to obtain a 
geometrical indicator for the accuracy of dose delivery based on 
analytical dose calculations for proton therapy fields. 
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Materials and Methods: Fourteen patients treated atour facility with 
passively scattered proton beams were selected. Aperture areas 
ranged from ~3 to ~35 cm2. Aperture sizes < 3 cm2 were not 
considered in this study because aperture scattering effects might 
outweigh effects from patient heterogeneities. Dose distributions 
predicted by our pencil beam (PB) algorithm were verified against MC 
dose calculations using TOPAS—a TOol for PArticle Simulation layered 
on top of GEANT4. Open field dosimetry was corrected based on the 
clinical guidelines for small fields to consider aperture scattering and 
dose equilibrium. DVHs were analyzed and differences in the dose to 
the 50% of the GTV (D50) were assessed on a field-by-field basis. We 
developed a simple and fast methodology to quantify the tissue 
inhomogeneity traversed by a single beam using a heterogeneity index 
(HI). The implementation was based on the dose calculation approach 
taken by our PB algorithm. Finally, we evaluated the potential 
correlation between the errors made by our PB algorithm in D50 for 
each field and the level of tissue heterogeneity traversed by the 
proton beam given by HI. 
Results: Discrepancies up to 5.4% were found in D50 ([D50PB—D50MC]/ 
D50MC). The discrepancies found for each field exhibited a strong 
correlation to their associated HI-values (Spearman's ρ = 0.8, p 
<0.0001); the higher the level of tissue heterogeneities for a 
particular field, the larger the dosimetric error by the analytical 
algorithm. With the established correlation a threshold for HI could be 
set by choosing a tolerance level; requiring an absolute difference for 
D50 < 2.5% for clinical routines suggests recalculation ofpatient 
treatments for HIt >> 1.7. 
 
  
Conclusions: The HI as defined in this study appeared to be a good 
indicator for theaccuracy of proton field delivery in terms of GTV 
prescription dose coverage. Each HI-value was obtained in less than 3 
minutes allowing the implementation of this methodology in the 
clinical routine. For HI-values exceeding the threshold, either a 
change in beam direction (if feasible) or a recalculationof the dose 
with Monte Carlo would be highly recommended.  
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Purpose/Objective: To validate experimentally a GATE/GEANT4-
based(G4) Monte Carlo (MC) model in heterogeneous media for 
dedicated pencil beam scanning in proton therapy. Comparisons 
between measurements and MC simulations using G4 and PENELOPE-
proton are presented. A comparison against analytical modeling from 
commercial TPS is also investigated. This work evaluates the impact 
of heterogeneities on range prediction, beam shape and depth dose 
changes. 
Materials and Methods: The MC model for pencil beam based on G4 
has been validated in water and PMMA phantoms (Grevillot et al Phys. 
Med. Biol.(2011)) reproducing pristine Bragg peaks for a series of 
individual energies (from 100 to 226.7 MeV) with 0.7 mm range and 
0.2 mm spot size accuracy. The same optical model was implemented 
in PENELOPE-proton. In order to validate the beam model in 
heterogeneous media, phantoms made of stacked slabs with different 
densities and known compositions were used. Two experimental test 
cases including solid water (SW), lung (LN-300) and bone (SB3) tissue-
equivalent material were investigated. Depth-dose distributions for a 
monoenergetic single spot and 10x10cm² composite fields were 
measured using Gafchromic EBT3 films and the ionization chamber 
(IC) PPC05 in all configurations. To measure accurately the Bragg peak 
position, a stack of films of 2x2cm² was inserted in the last 
centimeter of the proton range. 
Results: Figure 1 shows results for one heterogeneous configuration. 
All doses-to-medium were converted to dose to water using stopping 
power ratios. Dose distributions were arbitrarily normalized in the 
middle of the second SW region. Bragg peak positions are reproduced 
by MC simulations within 1mm in both configurations (Table 1). IC 
measurements, G4 (binary-cascade) and PENELOPE-proton simulations 
are within 2%/2 mm. Point-to-point mean difference of 1.2% is 
observed between G4 (precompound) and measurement in the first 15 
cm of the phantom and increased to 7.2% after bone insert until 
286.5mm depth. In lung and bone slabs, EBT3 films and G4 binary-
cascade are inagreement within 0.77% while a mean point-to-point 
difference up to 1.26% is observed with G4 precompound model. The 
uncertainty (1σ) on EBT3 films was evaluated to be at 2.75% which 
included readout process and dose calibration against IC (TRS-398). A 
statistical uncertainty of 0.1% was achieved for MC simulations. 
 
 
  
Conclusions: The Bragg peak position is predicted with 1mm precision 
for all MC simulations, even though ionization potential values for 
phantom slabs were calculated using classical additive rules. G4/GATE 
beam model reproduce depth-dose behavior of proton transport 
regarding both IC and EBT3 measurement in heterogeneities. 
This work is supported by the Walloon Region under the project 
name InVivoIGT, convention number 1017266. 
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Purpose/Objective: Currently, pencil beam dose calculation 
algorithms are commonly used in treatment planning for radiotherapy 
with protons. These algorithms are of limited accuracy in some 
situations such as patient heterogeneities, which could be overcome 
when using Monte Carlo (MC) methods. However, MC suffers from long 
